Nanjing Nuoling Biotechnology Co., Ltd.
诺令生物
Nanjing Nuoling Biotechnology Co., Ltd.
Biotech/Healthcare
Nuoling Bio focuses on nitric oxide (NO) generation, controlled release, and medical applications, with the goal of advancing the global use of NO to treat pulmonary hypertension and infectious diseases. It is China’s first medical device company dedicated to NO gas generation.
Latest round: Series B Extension (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-06-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.